CERYX MEDICAL LIMITED

Active Cardiff

Research and experimental development on biotechnology

8 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
C

CERYX MEDICAL LIMITED

Research and experimental development on biotechnology

Founded 12 Feb 2016 Active Cardiff, Wales 8 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 20 Aug 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 27 Mar 2026 Next due 10 Apr 2027 11 months remaining
Net assets £4M £234K 2024 year on year
Total assets £4M £261K 2024 year on year
Total Liabilities £57K £26K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

4th Floor, 14, Museum Place Cardiff CF10 3BH Wales

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for CERYX MEDICAL LIMITED (10001886), an active life sciences and medical technology company based in Cardiff, Wales. Incorporated 12 Feb 2016. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2017–2024)

Cash in Bank

N/A

Net Assets

£3.70M

Increased by £234.08k (+7%)

Total Liabilities

£56.81k

Increased by £26.43k (+87%)

Turnover

N/A

Employees

8

Debt Ratio

2%

Increased by 1 (+100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2
Grants 3

Investors (8)

Investor NameInvestor SinceParticipating Rounds
Investor 6Sept 2020Seed
Investor 7Sept 2020Seed
Investor 8Sept 2020Seed

Share Capital

Share Capital

Share allotments and capital structure

10 Allotments 105,039 Shares £9.55m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
4 Aug 2025678£6.78£0.01
4 Aug 2025678£6.78£0.01
10 Jun 202542,871£4.87m£113.65
31 Mar 202241,555£3.85m£92.75
21 Jul 2020260£0£0

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (47)

Mnl (parkwalk) Nominees Limited
18.6%
12,234
Dbw Investments (14) Limited
16.4%
10,781

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
27 Mar 2026Confirmation StatementConfirmation statement made on 2026-03-27 with updates
27 Feb 2026MiscellaneousReplacement filing of SH01 - 04/08/25 Statement of Capital gbp 1093.62
2 Feb 2026OfficersAppointment of Mr Mark Henry Strong as director on 2026-02-02
15 Sept 2025OfficersChange to director Mr Joseph Caddell on 2025-09-15
20 Aug 2025AccountsAnnual accounts made up to 2024-12-31
27 Mar 2026 Confirmation Statement

Confirmation statement made on 2026-03-27 with updates

27 Feb 2026 Miscellaneous

Replacement filing of SH01 - 04/08/25 Statement of Capital gbp 1093.62

2 Feb 2026 Officers

Appointment of Mr Mark Henry Strong as director on 2026-02-02

15 Sept 2025 Officers

Change to director Mr Joseph Caddell on 2025-09-15

20 Aug 2025 Accounts

Annual accounts made up to 2024-12-31

Recent Activity

Latest Activity

Confirmation statement made on 2026-03-27 with updates

3 weeks ago on 27 Mar 2026

Replacement filing of SH01 - 04/08/25 Statement of Capital gbp 1093.62

1 months ago on 27 Feb 2026

Appointment of Mr Mark Henry Strong as director on 2026-02-02

2 months ago on 2 Feb 2026

Change to director Mr Joseph Caddell on 2025-09-15

7 months ago on 15 Sept 2025

Annual accounts made up to 2024-12-31

8 months ago on 20 Aug 2025